REMSleep is preparing for the issuance of a new patent for its nasal ventilation system, while it finalizes plans to launch the Deltawave CPAP pillows interface later this year.
Summary: REMSleep Holdings Inc announced that the United States Patent and Trademark Office has allowed a utility patent for its nasal ventilation system, with the company expecting formal issuance in approximately eight weeks. As REMSleep prepares for the launch of its Deltawave CPAP pillows interface, it is finalizing regulatory compliance and waiting for raw materials to begin production. Additionally, the company plans to submit a 510K application for its next-generation Longevity CPAP pillows interface following the Deltawave launch.
Key Takeaways:
- Patent Approval for Nasal Ventilation System: REMSleep has received approval for a utility patent from the USPTO, with the formal issuance expected within eight weeks.
- Deltawave CPAP Interface Launch: The company is preparing to launch its Deltawave CPAP pillows interface, with production starting after receiving silicone materials in early October.
- Next-Generation CPAP Devices: After the Deltawave launch, REMSleep expects to submit a 510K application for its Longevity CPAP pillows interface and plans to release a third-generation mask by the end of 2025.
REMSleep Holdings Inc has announced that the United States Patent and Trademark Office has allowed a utility patent for its nasal ventilation system, with the company preparing for the patent’s issuance and the upcoming market launch of its Deltawave CPAP pillows interface.
REMSleep will file the necessary paperwork to pay for issuance and, thereafter, REMSleep should be awarded a patent in approximately eight weeks. REMSleep notes in a release that it will maintain a continuation application for adding any improvements and/or changes to the patent lineage.
Launching the Deltawave CPAP Pillows Interface
REMSleep is now waiting on the delivery of silicone raw materials to produce the inventory for the market launch of its US Food and Drug Administration (FDA)-cleared Deltawave CPAP pillows interface. The company expects the materials to arrive aapproximately the first week of October. Production should be available a few days after, and the company will begin shipping samples to distributors.
“During this period, we are making all necessary preparations to be fully regulatory compliant with FDA for the launch of the Deltawave CPAP pillows interface,” REMSleep Holdings notes in a release.
Next-Generation Masks
After the launch of the Deltawave, REMSleep intends to submit a 510K application for its next-generation Longevity CPAP pillows interface. The 510K application is expected to take approximately five months to clearance. The Longevity design is complete, and no additional research and development is needed, according to a release from the company.
There will be a third-generation CPAP interface mask to follow Longevity. “We expect to have the third-generation pillows mask to market by end of 2025. We expect REMSleep to be a substantial company by end of 2025,” according to a release from REM Sleep Holdings.
ID 127327341 © Jarretera | Dreamstime.com
